Man Group plc - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.

Quarter-by-quarter ownership
Man Group plc ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$246,000
-94.7%
43,000
-86.4%
0.00%
-95.7%
Q2 2020$4,636,000
+20.8%
315,161
+93.0%
0.02%
+76.9%
Q4 2019$3,839,000
+610.9%
163,328
+462.5%
0.01%
+550.0%
Q2 2019$540,000
-49.8%
29,036
-34.1%
0.00%
-50.0%
Q1 2019$1,076,000
-31.8%
44,040
-27.5%
0.00%
-42.9%
Q4 2018$1,577,000
+120.3%
60,782
+229.8%
0.01%
+133.3%
Q2 2018$716,00018,4320.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders